Sirtuin 1 regulates skeletal myoblast survival and enhances differentiation in the presence of resveratrol
The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Sirtuin 1 also known as NAD‐dependent deacetylase sirtuin 1, is a protein that in humans is encoded by the Sirt1 gene. Sirt1 is an enzyme that deacetylates proteins that contribute to cellular regulation and is a key regulator of cell defenses and survival in response to stress. Deletion of Sirt1 abolishes the increase in lifespan induced by calorie restriction or sublethal cytokine stress, indicating that Sirt1 promotes longevity and survival. We have demonstrated that administration of a sublethal dose of tumour necrosis factor‐α (TNF‐α; 1.25 ng ml−1) inhibits myotube formation, and co‐incubation with insulin‐like growth factor I (IGF‐I; 1.5 ng ml−1) facilitates C2 myoblast death rather than rescuing differentiation. A higher dose of TNF‐α (10 ng ml−1) resulted in significant apoptosis, which was rescued by IGF‐I (1.5 ng ml−1; 50% rescue; P < 0.05). We aimed to investigate the role of Sirt1 in the conflicting roles of IGF‐I. Quantitative real‐time PCR revealed that Sirt1 expression was elevated in myoblasts following incubation of 10 ng ml−1 TNF‐α or 1.25 ng ml−1 TNF‐α plus IGF‐I (fivefold and 7.2‐fold increases versus control, respectively; P < 0.05). A dose of 10 ng ml−1 TNF‐α induced ∼21 ± 0.7% apoptosis, which was reduced (∼50%; P < 0.05) when administered with IGF‐I. Likewise, Sirt1 expression was elevated following 10 ng ml−1 TNF‐α administration, but was reduced (∼30%; P < 0.05) in the presence of IGF‐I. C2C12 myoblasts, a subclone of the C2 cell line produced for their differentiation potential and used to examine intrinsic ageing, unlike C2 cells, do not die in the presence of TNF‐α and do not upregulate Sirt1. As conditions that induced the greatest myoblast stress/damage resulted in elevated Sirt1 expression, we investigated the effects of Sirt1 gene silencing. Treatment with 10 ng ml−1 TNF‐α or co‐incubation with 1.25 ng ml−1 TNF‐α and 1.5 ng ml−1 IGF‐I resulted in apoptosis (20.33 ± 2.08 and 19 ± 2.65%, respectively), which was increased when myoblasts were pretreated with Sirt1 small interfering RNA (31 ± 2.65 and 27.33 ± 2.52%, respectively; P < 0.05) and was reduced (14.33 ± 3.05%, P < 0.05 and 12.78 ± 4.52%, P= 0.054) by resveratrol, which also significantly rescued the block on differentiation. In conclusion, Sirt1 expression increases in conditons of stress, potentially serving to reduce or dampen myoblast death.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase
Cohen, H. Y., Miller, C., Bitterman, K. J., Wall, N. R., Hekking, B., Kessler, B., Howitz, K. T., Gorospe, M., de Cabo, R., & Sinclair, D. A. (2004) · Science · doi:10.1126/science.1099196 · Cited by 1,924
Calorie restriction–the SIR2 connection
Guarente, L., & Picard, F. (2005) · Cell · doi:10.1016/j.cell.2005.01.029 · Cited by 793 · cited 1×
“Seven sirtuins have been identified in mammals, of which Sirt1 is believed to mediate the beneficial effects of resveratrol on health and longevity (Guarente & Picard, 2005).”
BackgroundSpeakman, J. R., Talbot, D. A., Selman, C., Snart, S., McLaren, J. S., Redman, P., Krol, E., Jackson, D. M., Johnson, M. S., & Brand, M. D. (2004) · Aging Cell · doi:10.1111/j.1474-9728.2004.00097.x · Cited by 761
Substrate-specific activation of sirtuins by resveratrol
Kaeberlein, M., McDonagh, T., Heltweg, B., Hixon, J., Westman, E. A., Caldwell, S. D., Napper, A., Curtis, R., DiStefano, P. S., Fields, S., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500655200 · Cited by 745
Nicotinamide and PNC1 govern lifespan extension by calorie restriction in Saccharomyces cerevisiae
Anderson, R. M., Bitterman, K. J., Wood, J. G., Medvedik, O., & Sinclair, D. A. (2003) · Nature · doi:10.1038/nature01578 · Cited by 736 · cited 1×
“Deletion of Sirt1 in yeast abolishes the increase in lifespan induced by CR or sublethal levels of stress, indicating that Sirt1 is a mediator of signals that promote longevity (Anderson et al. 2003).”
BackgroundSirtuins in aging and age-related disease
Longo, V. D., & Kennedy, B. K. (2006) · Cell · doi:10.1016/j.cell.2006.07.002 · Cited by 628 · cited 1×
“Such phenotypic similarities of insulin–IGF-I pathways in different species raise the possibility that the fundamental mechanism of ageing may be evolutionarily conserved from yeast to mammals (Bonafè et al. 2003; Longo & Kennedy, 2006).”
BackgroundCaloric restriction and aging: an update
Masoro, E. J. (2000) · Experimental Gerontology · doi:10.1016/s0531-5565(00)00084-x · Cited by 615
Elevated levels of tumor necrosis factor alpha and mortality in centenarians
Bruunsgaard, H., Andersen-Ranberg, K., Hjelmborg, J. V. B., Pedersen, B. K., & Jeune, B. (2003) · The American Journal of Medicine · doi:10.1016/s0002-9343(03)00329-2 · Cited by 325 · cited 1×
“…with reduced muscle mass (Degens & Alway, 2003; Morse et al. 2005) and increased susceptibility to TNF-α-induced muscle protein degradation (Bruunsgaard et al. 2003a,b; Lees et al. 2009; Saini et al. 2009), this comparative model using C2 (susceptible) and C2C12 (resistant) provides us…”
BackgroundThe Sir2 family of protein deacetylases
Denu, J. M. (2005) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2005.08.010 · Cited by 325
Predicting death from tumour necrosis factor-alpha and interleukin-6 in 80-year-old people
BRUUNSGAARD, H., LADELUND, S., PEDERSEN, A. N., SCHROLL, M., JØRGENSEN, T., & PEDERSEN, B. K. (2003) · Clinical and Experimental Immunology · doi:10.1046/j.1365-2249.2003.02137.x · Cited by 300
Skeletal muscle function and hypertrophy are diminished in old age
Degens, H., & Alway, S. E. (2003) · Muscle & Nerve · doi:10.1002/mus.10314 · Cited by 125 · cited 1×
“As ageing and disease are associated with reduced muscle mass (Degens & Alway, 2003; Morse et al. 2005) and increased susceptibility to TNF-α-induced muscle protein degradation (Bruunsgaard et al. 2003a,b; Lees et al. 2009; Saini et al. 2009), this comparative model using C2 (susceptible) and C2C12…”
BackgroundPowerful signals for weak muscles
Saini, A., Faulkner, S., Al-Shanti, N., & Stewart, C. (2009) · Ageing Research Reviews · doi:10.1016/j.arr.2009.02.001 · Cited by 109 · cited 2×
“2005) and increased susceptibility to TNF-α-induced muscle protein degradation (Bruunsgaard et al. 2003a,b; Lees et al. 2009; Saini et al. 2009), this comparative model using C2 (susceptible) and C2C12 (resistant) provides us with an excellent representation of muscle atrophy, with intrinsic ageing represented by the…”
BackgroundSelf-citation
Cited by
Sharples, A. P., Stewart, C. E., & Seaborne, R. A. (2016) · Aging Cell · doi:10.1111/acel.12486 · Cited by 180
“…data that exist regarding the epigenetic control of muscle stem cells and the process of myogenesis and muscle stem cell function (reviewed in Dilworth & Blais, 2011; Segales et al., 2015; Laker & Ryall, 2016), including work by ourselves on the class III HDAC sirtuin 1 (Saini et al., 2012).”
BackgroundSelf-citationSaini, A., Sharples, A. P., Al-Shanti, N., & Stewart, C. E. (2017) · Biogerontology · doi:10.1007/s10522-016-9667-3 · Cited by 53
Girven, M., Dugdale, H. F., Owens, D. J., Hughes, D. C., Stewart, C. E., & Sharples, A. P. (2016) · Journal of Cellular Physiology · doi:10.1002/jcp.25380 · Cited by 48
Self-citationSarcopenia and cachexia: molecular mechanisms and therapeutic interventions
Wang, T., Zhou, D., & Hong, Z. (2025) · MedComm · doi:10.1002/mco2.70030 · Cited by 46
Metadata
- Authors
- Saini, A., Al‐Shanti, N., Sharples, A. P., & Stewart, C. E.
- Venue
- Experimental Physiology
- Publisher
- Wiley
- Published
- 2012-03
- Volume
- 97
- Issue
- 3
- Pages
- 400-418
- ISSN
- 0958-0670 (ISSN-L)
- 1469-445X
- OpenAlex
- W2137032156
- Cited by
- 44
- References
- 12
- FWCI
- 1.08
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.